Showing results (1-10 of 5) with videos related to
Sort By:
Pageof 1
Journal of Virus Eradication|October 27, 2025
A liberalized approach to directly observed therapy for HCV retains excellent cure rates among PWID in ViennaCaroline Schwarz, Angelika Schütz, Maximilian Anibas, et al.Plos One|June 4, 2021
Directly observed therapy at opioid substitution facilities using sofosbuvir/velpatasvir results in excellent SVR12 rates in PWIDs at high risk for non-adherence to DAA therapyCaroline Schmidbauer, Michael Schwarz, Angelika Schütz, et al.Journal of Virus Eradication|September 4, 2023
CHIME - A tailored HCV microelimination project in Viennese people who inject drugs at drug centralized substitution centersCaroline Schwarz, Raphael Schubert, Michael Schwarz, et al.Plos One|March 11, 2020
Directly observed therapy for HCV with glecaprevir/pibrentasvir alongside opioid substitution in people who inject drugs-First real world data from AustriaCaroline Schmidbauer, Raphael Schubert, Angelika Schütz, et al.European Journal of Gastroenterology & Hepatology|November 10, 2017
Efficacy of ledipasvir/sofosbuvir plus ribavirin for 12 weeks in patients with chronic hepatitis C genotype 3 and compensated liver diseaseStephan Moser, Karin Kozbial, Hermann Laferl, et al.Pageof 1